Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma

We conducted a prospective randomized phase II study to evaluate two chemotherapy regimens: (i) rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone (R-HCVAD) alternating with rituximab, high-dose methotrexate, and cytarabine (R-MA) and (ii) rituximab, cyclop...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Haematol
Egile Nagusiak: Oki, Yasuhiro, Westin, Jason R., Vega, Francisco, Chuang, Hubert, Fowler, Nathan, Neelapu, Sattva, Hagemeister, Fredrick B., McLaughlin, Peter, Kwak, Larry W., Romaguera, Jorge E., Fanale, Michelle, Younes, Anas, Rodriguez, Maria Alma, Orlowski, Robert Z., Wang, Michael, Ouzounian, Souzanne T., Samaniego, Felipe, Fayad, Luis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278952/
https://ncbi.nlm.nih.gov/pubmed/24117234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12585
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak